Abstract
Aim To determine the antiobesity effect and safety of glucagon-like peptide-1 receptor agonist (GLP-1RA) including liraglutide, exenatide and semaglut......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
